AAAAAA

   
Results: 1-13 |
Results: 13
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance
Authors: Rasmussen, T Fink-Jensen, A Sauerberg, P Swedberg, MDB Thomsen, C Sheardown, MJ Jeppesen, L Calligaro, DO DeLapp, NW Whitesitt, C Ward, JS Shannon, HE Bymaster, FP
Citation: T. Rasmussen et al., The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance, SCHIZOPHR R, 49(1-2), 2001, pp. 193-201
N-[3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl]-4-fluorobenzamide: A potent, selective, and orally active 5-HT1F receptor agonist potentially useful for migraine therapy
Authors: Xu, YC Johnson, KW Phebus, LA Cohen, M Nelson, DL Schenck, K Walker, CD Fritz, JE Kaldor, SW LeTourneau, ME Murff, RE Zgombick, JM Calligaro, DO Audia, JE Schaus, JM
Citation: Yc. Xu et al., N-[3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl]-4-fluorobenzamide: A potent, selective, and orally active 5-HT1F receptor agonist potentially useful for migraine therapy, J MED CHEM, 44(24), 2001, pp. 4031-4034
Receptor reserve of phosphoinositide-coupled muscarinic receptors in mousehippocampus in vivo
Authors: Bymaster, FP Carter, PA DeLapp, NW Calligaro, DO Felder, CC
Citation: Fp. Bymaster et al., Receptor reserve of phosphoinositide-coupled muscarinic receptors in mousehippocampus in vivo, BRAIN RES, 916(1-2), 2001, pp. 165-171
The novel 5-hydroxytryptamine(1A) antagonist LY426965: effects on nicotinewithdrawal and interactions with fluoxetine
Authors: Rasmussen, K Calligaro, DO Czachura, JF Dreshfield-Ahmad, LJ Evans, DC Hemrick-Luecke, SK Kallman, MJ Kendrick, WT Leander, JD Nelson, DL Overshiner, CD Wainscott, DB Wolff, MC Wong, DT Branchek, TA Zgombick, JM Xu, YC
Citation: K. Rasmussen et al., The novel 5-hydroxytryptamine(1A) antagonist LY426965: effects on nicotinewithdrawal and interactions with fluoxetine, J PHARM EXP, 294(2), 2000, pp. 688-700
Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice
Authors: Rasmussen, T Sauerberg, P Nielsen, EB Swedberg, MDB Thomsen, C Sheardown, MJ Jeppesen, L Calligaro, DO DeLapp, NW Whitesitt, C Ward, JS Shannon, HE Bymaster, FP Fink-Jensen, A
Citation: T. Rasmussen et al., Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice, EUR J PHARM, 402(3), 2000, pp. 241-246
Antagonism by olanzapine of dopamine D1, serotonin(2), muscarinic, histamine H-1 and alpha(1),-adrenergic receptors in vitro
Authors: Bymaster, FP Nelson, DL DeLapp, NW Falcone, JF Eckols, K Truex, LL Foreman, MM Lucaites, VL Calligaro, DO
Citation: Fp. Bymaster et al., Antagonism by olanzapine of dopamine D1, serotonin(2), muscarinic, histamine H-1 and alpha(1),-adrenergic receptors in vitro, SCHIZOPHR R, 37(1), 1999, pp. 107-122
Arachidonic acid release in cell tines transfected with muscarinic receptors: A simple functional assay to determine response of agonists
Authors: Bymaster, FP Calligaro, DO Falcone, JF
Citation: Fp. Bymaster et al., Arachidonic acid release in cell tines transfected with muscarinic receptors: A simple functional assay to determine response of agonists, CELL SIGNAL, 11(6), 1999, pp. 405-413
Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta
Authors: Sawyer, BD Bymaster, FP Calligaro, DO Falcone, J Mitch, CH Ward, JS Whitesitt, C Shannon, HE
Citation: Bd. Sawyer et al., Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta, GEN PHARM, 32(4), 1999, pp. 445-452
Potential role of muscarinic receptors in schizophrenia
Authors: Bymaster, FP Shannon, HE Rasmussen, K DeLapp, NW Ward, JS Calligaro, DO Mitch, CH Whitesitt, C Ludvigsen, TS Sheardown, M Swedberg, M Rasmussen, T Olesen, PH Jeppesen, L Sauerberg, P Fink-Jensen, A
Citation: Fp. Bymaster et al., Potential role of muscarinic receptors in schizophrenia, LIFE SCI, 64(6-7), 1999, pp. 527-534
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats
Authors: Shannon, HE Hart, JC Bymaster, FP Calligaro, DO Delapp, NW Mitch, CH Ward, JS Fink-Jensen, A Sauerberg, P Jeppesen, L Sheardown, MJ Swedberg, MDB
Citation: He. Shannon et al., Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats, J PHARM EXP, 290(2), 1999, pp. 901-907
1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives
Authors: Jeppesen, L Olesen, PH Hansen, L Sheardown, MJ Thomsen, C Rasmussen, T Jensen, AF Christensen, MS Rimvall, K Ward, JS Whitesitt, C Calligaro, DO Bymaster, FP Delapp, NW Felder, CC Shannon, HE Sauerberg, P
Citation: L. Jeppesen et al., 1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives, J MED CHEM, 42(11), 1999, pp. 1999-2006
Olanzapine: a basic science update
Authors: Bymaster, F Perry, KW Nelson, DL Wong, DT Rasmussen, K Moore, NA Calligaro, DO
Citation: F. Bymaster et al., Olanzapine: a basic science update, BR J PSYCHI, 174, 1999, pp. 36-40
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats
Authors: Fink-Jensen, A Kristensen, P Shannon, HE Calligaro, DO Delapp, NW Whitesitt, C Ward, JS Thomsen, C Rasmusseen, T Sheardown, MJ Jeppesen, L Sauerberg, P Bymaster, FP
Citation: A. Fink-jensen et al., Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats, NEUROREPORT, 9(15), 1998, pp. 3481-3486
Risultati: 1-13 |